HAEMOPHILIA A
Clinical trials for HAEMOPHILIA A explained in plain language.
Never miss a new study
Get alerted when new HAEMOPHILIA A trials appear
Sign up with your email to follow new studies for HAEMOPHILIA A, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug Mim8 shows promise for Long-Term bleeding prevention in hemophilia a
Disease control Recruiting nowThis study tests Mim8, a drug that helps blood clot by mimicking a missing protein, in people with hemophilia A (with or without inhibitors). Over 450 participants will receive injections for up to 5.5 years to see if it safely prevents bleeding episodes. The goal is to provide a…
Matched conditions: HAEMOPHILIA A
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Could a daily pill replace needles for hemophilia a?
Disease control Recruiting nowThis study tests an experimental oral medicine called Inno8 in 30 adults with hemophilia A. The goal is to see if it is safe and how the body processes it. Participants will take multiple doses over about 11 weeks. If successful, Inno8 could offer a more convenient way to control…
Matched conditions: HAEMOPHILIA A
Phase: PHASE1 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New hope for haemophilia a patients: immune tolerance induction may eliminate clotting factor blockers
Disease control Recruiting nowThis study looks at whether a treatment called immune tolerance induction (ITI) can help people with haemophilia A who have developed inhibitors—antibodies that block standard clotting factor therapy. Researchers will give high doses of individualized factor VIII concentrates to …
Matched conditions: HAEMOPHILIA A
Sponsor: Haemophilia Centre Rhine Main • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New hope for kids with hemophilia: can SCT800 stop bleeds before they start?
Disease control Recruiting nowThis study is testing a drug called SCT800, a lab-made clotting factor, to prevent bleeding episodes in 36 boys with severe hemophilia A who have never been treated before. Participants receive regular infusions of SCT800, and researchers will monitor how many bleeding events occ…
Matched conditions: HAEMOPHILIA A
Phase: PHASE3 • Sponsor: Sinocelltech Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Hemophilia a study observes how new patients respond to factor VIII in daily practice
Knowledge-focused Recruiting nowThis study is observing how well three Factor VIII concentrates (Nuwiq, Octanate, Wilate) work in real-world settings for people with severe hemophilia A who have had little or no prior treatment. Researchers will track bleeding rates and side effects in about 200 participants of…
Matched conditions: HAEMOPHILIA A
Sponsor: Octapharma • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC